"10.1371_journal.pone.0099789","plos one","2014-06-11T00:00:00Z","Marine Yeghiazaryan; Izabela Rutkowska-Wlodarczyk; Anna Konopka; Grzegorz M Wilczy≈Ñski; Armenuhi Melikyan; Eduard Korkotian; Leszek Kaczmarek; Izabela Figiel","Department of Neurophysiology, The Nencki Institute of Experimental Biology, Warsaw, Poland; Department of Molecular and Cellular Neurobiology, The Nencki Institute of Experimental Biology, Warsaw, Poland; D-Pharm Ltd, Kiryat Weizmann Science Park, Rehovot, Israel; Department of Neurobiology, Weizmann Institute, Rehovot, Israel","Conceived and designed the experiments: LK GMW. Performed the experiments: MY IF AK EK. Analyzed the data: MY IF IR-W AM. Contributed reagents/materials/analysis tools: LK GMW AM EK. Wrote the paper: LK GMW IF MY IR-W. Obtained permission for use animals: MY IF.","The authors declare that Armenuh Melikyan is an employee of D-Pharm and that D-Pharm provided the test compounds, free of charge, under a material transfer agreement, to the Kaczmarek group in Poland. D-Pharm has been, and is currently developing DP-b99 for acute ischemic stroke and acute pancreatitis, respectively. D-Pharm is currently sponsoring a small Phase 2 clinical trial in acute pancreatitis. D-Pharm and the Kaczmarek group were previously part of the FP7 funded Plasticise consortium, under whose auspices the collaboration originally started. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","06","Marine Yeghiazaryan","MY",8,TRUE,2,4,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
